Medical Economics December 9, 2024
Salvatore J. Giorgianni

Key Takeaways

  • PBMs control drug access, negotiating discounts but retaining savings, leading to high patient costs and nonadherence.
  • Bipartisan bills propose reforms to delink PBM compensation from drug prices and base patient cost-sharing on net prices.
  • PBM practices contribute to preventable deaths, increased healthcare costs, and strain on healthcare systems.
  • Reforming PBM practices is crucial for a transparent, patient-centered system, with strong bipartisan support for change.

PBMs are powerful middlemen that control prescription drug access for millions of Americans, and their business model is nefarious — but currently legal.

Concerns about high drug prices can take a significant toll on Americans every day. A new West Health-Gallup study recently found that a mere 55% of Americans believe they...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Congress / White House, Govt Agencies, Pharma, Pharma / Biotech
Congressional spending plan: What’s in it for healthcare, and what isn’t
Despite Trump’s Tough Talk On PBMs, GOP House Lets Them Off The Hook
Telehealth groups call for urgent action as Medicare flexibility deadline looms
Another House bill aims to protect against hospital cyberattacks
A health care earthquake in Congress

Share This Article